SREBF1 and metabolic dysfunction-associated steatotic liver disease: The notion that mTORC1 promotes lipogenesis and may contribute to NAFLD came from a series of observations showing the positive effects of mTORC1 on SREBP1 expression and activity that lead to de novo lipid synthesis [8], [9], [10], [11], [14], [39].